JULIA WOOD: Open Payments
NPI 1245435825 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 69 payments from 15 companies in 2025. Trend: 2023 $1,109 · 2024 $977 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $291 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $140 |
| Neos Therapeutics, LP | 6 | $114 |
| Vanda Pharmaceuticals Inc. | 5 | $86 |
| Alkermes, Inc. | 4 | $79 |
| Lundbeck LLC | 3 | $58 |
| Corium, LLC | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
Products named: INGREZZA, CAPLYTA, TRINTELLIX, Adzenys XR-ODT, REXULTI, LYBALVI, Azstarys, FANAPT.
Industry payments across TN — which companies pay providers there.
